The effects of 2-MG, RBP, and CRP on the diagnosis and prediction of the treatment outcomes of diabetic microangiopathy

Yu Lu,Qingqing Zhang,Shufang Yang,Xi Chen,Yanyan Li,Xiaoqiang Fei
2020-01-01
Abstract:Objective: This study aims to investigate the diagnostic performance of serum high sensitivity C-reactive protein (CRP), urinary retinol-binding protein (RBP), and beta 2 microglobulin (beta 2-MG) for diabetic microangiopathy. Methods: A total of 146 patients with diabetes admitted to our hospital from February 2016 to February 2019 were selected as subjects. Among them, 76 patients with microvascular disease were included in the study group, and the other 70 patients without microvascular disease were enrolled in the control group. 5 mL of venous blood was collected before and after treatment, which was placed at room temperature for 30 min and centrifuged (4000 rpm/min) for 10 min to obtain upper serum. The serum beta 2-MG and RBP levels were measured using chemiluminescence and immunoturbidimetry, respectively, and the CRP levels were measured using a fully automated specialty protein analyzer. The clinical efficacy of the treatment was recorded. The diagnostic value of the combined RBP, beta 2-MG, and CRP for diabetic microangiopathy was analyzed using an ROC curve. The predictive value of combined RBP, beta 2-MG, and CRP for therapeutic outcomes was also analyzed using an ROC curve. The risk factors associated with diabetic microangiopathy were analyzed as well. Results: The serum levels of RBP, beta 2-MG, and CRP in the study group were significantly higher than they were in the control group (P<0.05), but after treatment, there were no significant differences in the serum levels of RBP, beta 2-MG, and CRP in both groups (P>0.05), and the RBP level was still higher than it was in the control group (P<0.05). After treatment, the serum levels of RBP, beta 2-MG, and CRP decreased in both groups compared with the levels before treatment (P<0.05). According to an ROC curve analysis, the diagnostic sensitivity for diabetic microangiopathy was 86.00%, and the specificity was 94.00% (P<0.001). The effective sensitivity for diabetic microangiopathy patients was 80.00%, and the specificity was 90.00% (P<0.001). A logistic regression analysis showed that RBP, beta 2-MG, and CRP are independent protective factors for diabetic microangiopathy (OR>1, P<0.05). Conclusion: The serum levels of beta 2-MG, RBP, and CRP in patients with diabetic microangiopathy are higher than they are in healthy populations. The combined measurement of beta 2-MG, RBP, and CRP has a good efficacy in the diagnosis and prediction of the treatment outcomes of diabetic microangiopathy.
What problem does this paper attempt to address?